Linear IgA bullous disease presenting as toxic epidermal necrolysis: A case report and review of the literature

Dermatology

Volumn 227, Issue 3, 2013, Pages 209-213

  Kakar, Rohit ^a   Paugh, Holly ^a   Jaworsky, Christine ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Bullous disease; Linear IgA bullous dermatosis; Toxic epidermal necrolysis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; DAPSONE; IMMUNOGLOBULIN A; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ACUTE CHOLECYSTITIS; AGED; ARTICLE; BASEMENT MEMBRANE; BULLOUS SKIN DISEASE; BURN UNIT; CASE REPORT; COMORBIDITY; CROHN DISEASE; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; END STAGE RENAL DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HISTOPATHOLOGY; HOSPITAL; HUMAN; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; LINEAR IMMUNOGLOBULIN A BULLOUS DISEASE; MEDICAL HISTORY; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKIN DEFECT; SKIN EXFOLIATION; TOXIC EPIDERMAL NECROLYSIS; VENA CAVA FILTER; VERY ELDERLY;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FATAL OUTCOME; FEMALE; HUMANS; LINEAR IGA BULLOUS DERMATOSIS; STEVENS-JOHNSON SYNDROME;

EID: 84890130429     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000353584     Document Type: Article

References (35)

1. Fortuna G, Marinkovich PM. Linear immunoglobulin A bullous dermatosis. Clin Dermatol 2012; 30: 38-50
2. Dellavalle RP, Burch JM, Tayal S, Golitz LE, Fitzpatrick JE, Walsh P. Vancomycin associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. J Am Acad Dermatol 2003; 48:S56-S57
3. Leonard JN, Griffith CEM, Powles AV, et al. Experience with a gluten free diet in the treatment of linear IgA disease. Acta Derm Venereol 1987; 67: 145-148
4. Egan CA, Meadows KP, Zone J. Ulcerative colitis and immunobullous disease cured by colectomy. Arch Dermatol 1999; 135: 214-215
5. Barberis C, Doutre MS, Bioulac-Sage P, et al. Dermatose bulleuse à IgA linéaire associée à une maladie De Crohn. Gastroenterol Clin Biol 1988; 12: 76-77
6. McEvoy MT, Connolly SM. Linear IgA bullous dermatosis: association with malignancy. J Am Acad Dermatol 1990; 22: 59-63
7. Sekula SA, Tschen JA, Bean SF, Wolf JE Jr. Linear IgA bullous disease in a patient with transitional cell carcinoma of the bladder. Cutis 1986; 38: 354-356, 362
8. Lacour JP, Vitetta A, Ortonne JP. Linear IgA dermatosis and thyroid carcinoma. J Am Acad Dermatol 1992; 26: 257-259
9. Barrow-Wade L, Jordan RE, Arnett FC Jr. Linear IgA bullous dermatosis associated with dermatomyositis (letter). Arch Dermatol 1992; 128: 413-414
10. Blickenstaff RD, Perry HO, Peters MS. Linear IgA deposition associated with cutaneous varicella-zoster infection: a case report. J Cutan Pathol 1988; 15: 49-52
11. Buchvald J, Filo V, Horvathova J. IgA-linear dermatosis imitating Lyell syndrome. Bratisl Lek Listy 1987; 88: 211-217
12. Paul D, Wolkenstein P, Prost C, Caux F, Rostoker G, Heller M, Wechsler J, Revuz J, Roujeau JC. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol 1997; 136: 406-411
13. Wetterwald E, Le Cleach L, Wechsler J, Roujeau JC, Revuz J, Bagot M. Bullous drug eruption masquerading as toxic epidermal necrolysis. Eur Rencontres Hop 1999; 45: 15-18
14. Schneck B, Termeer C, Mockenhaupt M, Augustin M, Schopf E. Linear IgA dermatosis in an adult with clinical signs of Stevens-Johnson syndrome. Hautarzt 1999; 50: 288-291
15. Mofid MZ, Costarangos C, Bernstein B, Wong L, Munster A, Nousari HC. Drug-induced linear immunoglobulin A bullous disease that clinically mimics toxic epidermal necrolysis. J Burn Care Rehabil 2000; 21: 246-247
16. Hughes AP, Callen JP. Drug-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. Dermatology 2001; 202: 138-139
17. Tran D, Kossard S, Shumack S. Phenytoininduced linear IgA dermatosis mimicking toxic epidermal necrolysis. Australas J Dermatol 2003; 44: 284-286
18. Waldman MA, Black DR, Callen JP. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol 2004; 29: 633-636
19. Coelho S, Tellechea O, Reis JP, Mariano A, Figueiredo A. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. Int J Dermatol 2006; 137: 995-996
20. Cummings JE, Snyder RR, Kelly EB, Raimer SS. Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report. Cutis 2007; 79: 203-207
21. Khan I, Hughes R, Curran R, Marren P. Drugassociated linear IgA disease mimicking toxic epidermal necrolysis. Clin Exp Dermatol 2009; 34: 715-717
22. Trufant JW, Christensen SR, McNiff JM, Choi JN. Erythroderma and spontaneous blistering in a 49-year-old man. Arch Dermatol 2010; 146: 1419-1424
23. Schroeder D, Saada D, Rafaa M, Ingen-Housz-Oro S, Valeyrie-Alannore L, Siggal ML. Verapamil-induced linear IgA disease mimicking toxic-epidermal necrolysis. Ann Dermatol Venereol 2011; 138: 302-306
24. Jheng-Wei L, Yi-Chin S, Wen-Hung C. Vancomycin-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. Indian J Dermatol Venereol Leprol 2011; 77: 537
25. Zone JJ, Taylor TB, Kadunce DP, Meyer LJ. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest 1990; 85: 812-820
26. Marinkovich MP, Taylor TB, Keene DR, Burgeson RE, Zone JJ. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996; 106: 734-738
27. Collier P, Wojnarowska F, Allen J, Kirtschig G. Molecular overlap of the IgA target antigens in the subepidermal blistering diseases. Dermatology 1994; 189(suppl 1):105-107
28. Kanitakis J, Mauduit G, Cozzani E, Badinand P, Faure M, Claudy A. Linear IgA bullous dermatosis of childhood with autoantibodies to a 230 kDa epidermal antigen. Pediatr Dermatol 1994; 11: 139-144
29. Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem 1998; 273: 9711-9717
30. Zone JJ, Taylor TB, Meyer LJ, Petersen MJ. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 1998; 110: 207-210
31. Allen J, Phan TT, Hughes MA, Cherry GW, Wojnarowska F. The cellular origins of the linear IgA disease target antigens: an indirect immunofluorescence study using cultured human keratinocytes and fibroblasts. Br J Dermatol 2003; 148: 945-953
32. Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP. A critical reappraisal of the current data on drug induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity?. J Am Acad Dermatol 2012; 66: 988-994
33. Lissia M, Mulas P, Bulla A, Rubino C. Toxic epidermal necrolysis (Lyells disease). Burns 2010; 36: 152-163
34. Klein PA, Callen JP. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol 2000; 42: 316-323
35. Walsh S, Kerchner K, Sangueza OP. Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels. Arch Dermatol 2009; 145: 603-604